• Latest Posts
In Depth 28 Nov 2017

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Close to Launching Gene Therapy, Dutch Biotech Raises Over $91M on the Nasdaq

Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia

A €344M Partnership will Develop Bicycle Drugs for Hemophilia

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Sanofi and US Partner Launch Phase III Trial in Hemophilia with RNAi

Interview 19 Jun 2017

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

EMA designates uniQure’s gene therapy for hemophilia a priority

It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?

The FDA gives Fast Track Priority to uniQure’s Hemophilia B Gene Therapy

UPDATE: UniQure keeps afloat with a New CEO and More Clinical Data